rs61753721

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_017890.5(VPS13B):​c.2485G>A​(p.Ala829Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0111 in 1,613,582 control chromosomes in the GnomAD database, including 129 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0082 ( 8 hom., cov: 32)
Exomes 𝑓: 0.011 ( 121 hom. )

Consequence

VPS13B
NM_017890.5 missense

Scores

2
16

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:15O:1

Conservation

PhyloP100: 2.94

Publications

10 publications found
Variant links:
Genes affected
VPS13B (HGNC:2183): (vacuolar protein sorting 13 homolog B) This gene encodes a potential transmembrane protein that may function in vesicle-mediated transport and sorting of proteins within the cell. This protein may play a role in the development and the function of the eye, hematological system, and central nervous system. Mutations in this gene have been associated with Cohen syndrome. Multiple splice variants encoding distinct isoforms have been identified for this gene. [provided by RefSeq, Jul 2008]
VPS13B Gene-Disease associations (from GenCC):
  • Cohen syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Myriad Women’s Health, Labcorp Genetics (formerly Invitae), G2P, Genomics England PanelApp, Laboratory for Molecular Medicine, ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.006864518).
BP6
Variant 8-99193027-G-A is Benign according to our data. Variant chr8-99193027-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 95839.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00823 (1253/152230) while in subpopulation NFE AF = 0.0126 (858/67986). AF 95% confidence interval is 0.0119. There are 8 homozygotes in GnomAd4. There are 597 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 8 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
VPS13BNM_017890.5 linkc.2485G>A p.Ala829Thr missense_variant Exon 17 of 62 ENST00000358544.7 NP_060360.3 Q7Z7G8-1
VPS13BNM_152564.5 linkc.2485G>A p.Ala829Thr missense_variant Exon 17 of 62 ENST00000357162.7 NP_689777.3 Q7Z7G8-2
VPS13BNM_015243.3 linkc.2485G>A p.Ala829Thr missense_variant Exon 17 of 18 NP_056058.2 Q7Z7G8-4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
VPS13BENST00000358544.7 linkc.2485G>A p.Ala829Thr missense_variant Exon 17 of 62 1 NM_017890.5 ENSP00000351346.2 Q7Z7G8-1
VPS13BENST00000357162.7 linkc.2485G>A p.Ala829Thr missense_variant Exon 17 of 62 1 NM_152564.5 ENSP00000349685.2 Q7Z7G8-2

Frequencies

GnomAD3 genomes
AF:
0.00824
AC:
1254
AN:
152112
Hom.:
8
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00208
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0119
Gnomad ASJ
AF:
0.0104
Gnomad EAS
AF:
0.000192
Gnomad SAS
AF:
0.00331
Gnomad FIN
AF:
0.00500
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0126
Gnomad OTH
AF:
0.0105
GnomAD2 exomes
AF:
0.00867
AC:
2178
AN:
251160
AF XY:
0.00883
show subpopulations
Gnomad AFR exome
AF:
0.00154
Gnomad AMR exome
AF:
0.00969
Gnomad ASJ exome
AF:
0.0105
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00553
Gnomad NFE exome
AF:
0.0122
Gnomad OTH exome
AF:
0.0126
GnomAD4 exome
AF:
0.0114
AC:
16593
AN:
1461352
Hom.:
121
Cov.:
31
AF XY:
0.0111
AC XY:
8089
AN XY:
726980
show subpopulations
African (AFR)
AF:
0.00158
AC:
53
AN:
33466
American (AMR)
AF:
0.00970
AC:
434
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.0105
AC:
273
AN:
26118
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39614
South Asian (SAS)
AF:
0.00526
AC:
454
AN:
86240
European-Finnish (FIN)
AF:
0.00513
AC:
273
AN:
53268
Middle Eastern (MID)
AF:
0.00330
AC:
19
AN:
5762
European-Non Finnish (NFE)
AF:
0.0130
AC:
14430
AN:
1111788
Other (OTH)
AF:
0.0109
AC:
656
AN:
60376
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.457
Heterozygous variant carriers
0
875
1750
2625
3500
4375
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
554
1108
1662
2216
2770
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00823
AC:
1253
AN:
152230
Hom.:
8
Cov.:
32
AF XY:
0.00802
AC XY:
597
AN XY:
74428
show subpopulations
African (AFR)
AF:
0.00207
AC:
86
AN:
41554
American (AMR)
AF:
0.0118
AC:
181
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.0104
AC:
36
AN:
3468
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5184
South Asian (SAS)
AF:
0.00332
AC:
16
AN:
4824
European-Finnish (FIN)
AF:
0.00500
AC:
53
AN:
10608
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0126
AC:
858
AN:
67986
Other (OTH)
AF:
0.0104
AC:
22
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
68
136
204
272
340
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0105
Hom.:
27
Bravo
AF:
0.00822
TwinsUK
AF:
0.0121
AC:
45
ALSPAC
AF:
0.0125
AC:
48
ESP6500AA
AF:
0.00204
AC:
9
ESP6500EA
AF:
0.0121
AC:
104
ExAC
AF:
0.00857
AC:
1040
Asia WGS
AF:
0.00173
AC:
6
AN:
3478
EpiCase
AF:
0.0118
EpiControl
AF:
0.0123

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:15Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:7Other:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Sep 28, 2017
Athena Diagnostics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
GenomeConnect, ClinGen
Significance:not provided
Review Status:no classification provided
Collection Method:phenotyping only

Variant interpreted as Benign and reported on 04-27-2020 by Lab or GTR ID 500031. GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant. This variant was reported in an individual referred for clinical diagnostic genetic testing. -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Nov 30, 2016
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

May 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

VPS13B: BP4, BS1, BS2 -

Aug 01, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 16648375, 19006247) -

-
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not specified Benign:4
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. -

Mar 27, 2013
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Cohen syndrome Benign:3
Dec 06, 2019
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to rule this variant out of causing disease. Therefore, this variant is classified as benign. -

Inborn genetic diseases Benign:1
Apr 07, 2017
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.071
BayesDel_addAF
Benign
-0.46
T
BayesDel_noAF
Benign
-0.42
CADD
Benign
20
DANN
Benign
0.12
DEOGEN2
Benign
0.056
.;.;T
Eigen
Benign
-0.17
Eigen_PC
Benign
-0.10
FATHMM_MKL
Uncertain
0.84
D
LIST_S2
Benign
0.69
T;T;T
MetaRNN
Benign
0.0069
T;T;T
MetaSVM
Benign
-0.70
T
MutationAssessor
Benign
1.9
M;M;M
PhyloP100
2.9
PrimateAI
Benign
0.40
T
PROVEAN
Benign
-0.63
N;N;N
REVEL
Benign
0.14
Sift
Benign
0.75
T;T;T
Sift4G
Uncertain
0.060
T;T;T
Polyphen
0.62
P;D;B
Vest4
0.19
MVP
0.68
MPC
0.12
ClinPred
0.021
T
GERP RS
3.9
Varity_R
0.11
gMVP
0.25
Mutation Taster
=89/11
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs61753721; hg19: chr8-100205255; COSMIC: COSV99050300; API